Ipsilateral axillary lymphadenopathy after COVID-19 vaccination in a young female, a case report and literature review
Anaesthesia, Pain and Intensive Care
; 26(6):820-823, 2022.
Article
in English
| EMBASE | ID: covidwho-2206285
ABSTRACT
It has been two years since vaccination for COVID-19 was launched worldwide. In Pakistan, the vaccination started in the beginning of 2020. Since then, several side effects were reported after vaccination, including soreness of the arm, fever, chills, malaise and diarrhoea. Axillary lymphadenopathy has been found to be associated with several conditions that include autoimmune disorders, infections, malignancy and some idiopathic causes. We present a rare case of a 30-y old female with recent recovery from COVID-19, who developed ipsilateral axillary lymphadenopathy after 15 days of Sinovac vaccination. Ultrasonography was done to confirm the diagnosis and its spread towards breast and cervical region. This case report discusses some key points and recommendations regarding unilateral axillary lymphadenopathy after COVID-19 vaccination. Copyright © 2022 Faculty of Anaesthesia, Pain and Intensive Care, AFMS. All rights reserved.
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Case report
/
Reviews
Topics:
Vaccines
Language:
English
Journal:
Anaesthesia, Pain and Intensive Care
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS